Dr. Ravi Salgia: Lung Cancer & Pleural Mesothelioma Doctor

Quick Facts

Primary Location:
City of Hope Comprehensive Cancer Center
Expertise:
Immunotherapy
Drug Development
Speciality:
Thoracic Oncology
Gender:
Male
Language:
English, Hindi
Med School:
Loyola University School of Medicine

Get to Know Dr. Ravi Salgia

Medical oncologist Dr. Ravi Salgia specializes in the treatment of lung cancer and pleural mesothelioma, focusing his research on the molecular mutations in thoracic malignancies.

In his role at City of Hope Comprehensive Cancer Center, he works to create novel medicines designed to treat patients more effectively. He also treats thymic malignancies and bronchial carcinoids.

Salgia has earned a reputation as both an innovator and a healer. He joined City of Hope in 2016 after 12 years at the University of Chicago Comprehensive Cancer Center, where he directed the thoracic oncology program and helped pioneer the growth of immunotherapy.

He has been instrumental in expanding City of Hope’s clinical trials program. He also serves on various panels for the National Cancer Institute, including the Thoracic Malignancy Steering Committee.

Salgia’s advanced research regularly receives funding from the National Institutes of Health.

Contact Dr. Ravi Salgia

800-826-4673

Dr. Jacques Fontaine and Dr. Virginia Wolf

Find a Top Mesothelioma Doctor

Gain access to top mesothelioma doctors and get help scheduling appointments.

Connect Now

Specialties of Dr. Ravi Salgia

Lung cancer
Pleural mesothelioma
Immunotherapy
Research
Targeted therapies
Drug development

Dr. Ravi Salgia’s Experience and Medical Education

City of Hope Comprehensive Cancer Center
Chicago Comprehensive Cancer Center
Dana-Farber Cancer Institute, Brigham and Women’s Hospital (Fellowships)
Johns Hopkins Hospital (Residency)
Loyola University School of Medicine (M.D., Ph.D.)

Awards and Certifications

American Board of Internal Medicine
Top Doctors in America
Sun Pharma Research Awards, Clinical Research
Chicago magazine’s Top Doctors
IACA Award for Outstanding Contributions to Oncology
Los Angeles Business Journal, Top Doctor

Publications of Dr. Ravi Salgia

Salgia, R. et al. (2020, July). The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping. Cancer Treatment Reviews.
Rajurkar, S. et al. (2020, June 15). Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies. Journal of Clinical Medicine.
Gong, J. & Salgia, R. (2018, June). Managing Patients With Relapsed Small-Cell Lung Cancer. Journal of Oncology Practice.
Salgia, R. et al. (2018, May 25). Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models. Oncotarget.